Previous Article | Next Article 
Molecular and Cellular Biology, February 2002, p. 1073-1078, Vol. 22, No. 4
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.22.4.1073-1078.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
The Catalytic Activity of the ErbB-2 Receptor Tyrosine Kinase Is Essential for Embryonic Development
Richard Chan,1 William R. Hardy,1 Michael A. Laing,1 Sarah E. Hardy,1 and William J. Muller1,2,3*
Departments of Biology,1
Biochemistry,2
Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada L8S 4K13
Received 17 September 2001/
Returned for modification 25 October 2001/
Accepted 2 November 2001
Activation of the epidermal growth factor receptor (EGFR) family is thought to play a critical role in both embryogenesis and oncogenesis. The diverse biological activities of the EGFR family are achieved through various ligand-receptor and receptor-receptor interactions. One receptor that has been found to play a central role in this signaling network is ErbB-2/Neu, and it is considered the preferred heterodimerization partner for other members of the EGFR family. To assess the importance of the catalytic activity of ErbB-2 in embryonic development, we have generated mice expressing a kinase-dead erbB-2 cDNA under the transcriptional control of the endogenous promoter. Here, we show that mice homozygous for the kinase-dead erbB-2 allele die at midgestation and display the same spectrum of embryonic defects seen in erbB-2 knockout mutants. These observations suggest that the catalytic activity of ErbB-2 is essential for normal embryonic development.
* Corresponding author. Mailing address: McMaster University, Life Sciences Building 327, 1280 Main St. West, Hamilton, Ontario, Canada L8S 4K1. Phone: (905) 525-9140, ext. 27306. Fax: (905) 521-2955. E-mail:
mullerw{at}mcmaster.ca.
Molecular and Cellular Biology, February 2002, p. 1073-1078, Vol. 22, No. 4
0022-538X/01/$04.00+0 DOI: 10.1128/MCB.22.4.1073-1078.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Fan, Y.-X., Wong, L., Ding, J., Spiridonov, N. A., Johnson, R. C., Johnson, G. R.
(2008). Mutational Activation of ErbB2 Reveals a New Protein Kinase Autoinhibition Mechanism. J. Biol. Chem.
283: 1588-1596
[Abstract]
[Full Text]
-
Nethery, D. E., Moore, B. B., Minowada, G., Carroll, J., Faress, J. A., Kern, J. A.
(2005). Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice. J. Appl. Physiol.
99: 298-307
[Abstract]
[Full Text]
-
Khoury, H., Naujokas, M. A., Zuo, D., Sangwan, V., Frigault, M. M., Petkiewicz, S., Dankort, D. L., Muller, W. J., Park, M.
(2005). HGF Converts ErbB2/Neu Epithelial Morphogenesis to Cell Invasion. Mol. Biol. Cell
16: 550-561
[Abstract]
[Full Text]
-
Chan, R., Hardy, W. R., Dankort, D., Laing, M. A., Muller, W. J.
(2004). Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development. Development
131: 5551-5560
[Abstract]
[Full Text]
-
Andrechek, E. R., Hardy, W. R., Laing, M. A., Muller, W. J.
(2004). Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis. Proc. Natl. Acad. Sci. USA
101: 4984-4989
[Abstract]
[Full Text]
-
Leone, F., Perissinotto, E., Cavalloni, G., Fonsato, V., Bruno, S., Surrenti, N., Hong, D., Capaldi, A., Geuna, M., Piacibello, W., Aglietta, M.
(2003). Expression of the c-ErbB-2/HER2 proto-oncogene in normal hematopoietic cells. J. Leukoc. Biol.
74: 593-601
[Abstract]
[Full Text]
-
Andrechek, E. R., Hardy, W. R., Girgis-Gabardo, A. A., Perry, R. L. S., Butler, R., Graham, F. L., Kahn, R. C., Rudnicki, M. A., Muller, W. J.
(2002). ErbB2 Is Required for Muscle Spindle and Myoblast Cell Survival. Mol. Cell. Biol.
22: 4714-4722
[Abstract]
[Full Text]